-
Featured
Innovations in ALS Clinical Trials
Merit Cudkowicz, MD, MSc, chief of Neurology at Massachusetts General Hospital, discusses innovations in ALS clinical trials since she started in the field in 1994.
-
Featured
Advancements in the Treatment of Neurodegenerative Disease
In this video, Ghazaleh Sadri-Vakili, PhD, director of the NeuroEpigenetics Laboratory and the MassGeneral Institute of Neurodegenerative Disease, discusses her genetic research, specifically concerning neurodegenerative diseases like ALS and X-linked dystonia parkinsonism.
-
Featured
Identifying New Potential Therapeutic Targets for ALS FTD
Transcripts of repeat expansions in the C90RF72 gene undergo a repeat-associated non-AUG (RAN) translation pathway that generates multiple aberrant proteins. Researchers at Mass General Hospital identified new potential therapeutic targets for ALS FTD.
-
Novel Imaging Method Could Help Screen Subjects, Select Drug Doses for ALS Trials
Working in partnership, neurologists and radiologists at Massachusetts General Hospital have developed a novel molecular imaging method that measures glial activation in ALS that could assist in early trials of investigational drugs.
-
Biomarkers to Accelerate ALS Therapy Development
In this video, Dr. Merit Cudkowicz, MD, MSc, chief of Neurology, discusses biomarkers that can help to diagnose patients quicker and target individualized treatments to patients.
-
Innovations in Care for Patients with ALS
In this video, Merit Cudkowicz, MD, MSc, chief of Neurology, discusses innovations in care for patients with ALS, such as the House Call Program and TeleNeurology at Massachusetts General Hospital.
ALS contributors
-
Clotilde Lagier-Torurenne, MD, PhD
Assistant Professor of Neurology, Harvard Medical School, Assistant in Neuroscience, Massachusetts General Hospital
Recent Article
Identifying New Potential Therapeutic Targets for ALS FTD -
Ghazaleh Sadri-Vakili, MS, PhD
Assistant in Neuroscience, Massachusetts General Hospital, Assistant Professor of Neurology, Harvard Medical School
Recent Article
Advancements in the Treatment of Neurodegenerative Disease -
Merit Ester Cudkowicz, MD, MSc
Chief, Neurology Service, Director of Neurological Clinical Research Institute and the Jilieane Dorn Professor of Neurology, Harvard Medical School
Recent Article
Biomarkers to Accelerate ALS Therapy Development
-
Nazem Atassi, MD
Associate Director, Neurological Clinical Research Institute (NCRI), Mass General Hospital, Associate Professor of Neurology, Harvard Medical School
Recent Article
Novel Imaging Method Could Help Screen Subjects, Select Drug Doses for ALS Trials
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.Resource Links
